Jump Financial’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
Jump Financial's TXG Position: Q2 2026 in Review
Jump Financial sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 10,830 shares — an estimated $230K sold.
Jump Financial first reported a position in TXG in Q4 2021 and held it in 16 quarters. The position peaked at $12.1M in Q2 2025. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- Jump Financial reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
- Jump Financial sold 10,830 10x Genomics shares in Q2 2026, an estimated $230K.
- Jump Financial first reported a position in 10x Genomics in Q4 2021 and held it in 16 quarters.
- Jump Financial's 10x Genomics position peaked at $12.1M in Q2 2025.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.